期刊
JOURNAL OF NATURAL PRODUCTS
卷 77, 期 2, 页码 250-257出版社
AMER CHEMICAL SOC
DOI: 10.1021/np4007712
关键词
-
资金
- Romanian National Authority for Scientific Research, National Research Council, Executive Unit
- Higher Education, Research, Development and Innovation [PN-II-RU-TE-2011-3-0204, PN-II-IDEI-PCE-2011-3-0800, SK-RO-0016-12]
- Hungarian Scientific Research Fund [K103906, NK101337]
- Baross Gabor Program [REG_EA_09_1_2009-0010]
- European Union
- European Social Fund [TAMOP-4.2.2.-08/1-2008-0019, TAMOP-4.2.1.B-09/1/KONV-2010-0007, TAMOP-4.2.2.A-11/1/KONV-2012-0025]
- [TAMOP-4.2.2/B-10/1-2010-0024]
Since the administration of synthetic medicines is associated with drug resistance and undesired side effects, utilization of natural compounds could be an alternative and complementary modality to inhibit or prevent the development of tumors. Epigallocatechin 3-O-gallate (EGCG, 1), the major flavan component of green tea, and genistein (2), a soy isoflavonoid, are known to have chemopreventive and chemotherapeutic effects against cancer. This study demonstrated that both flavonoids inhibit cell proliferation, an effect enhanced under serum-free conditions. Compound 1, but not 2, induced downregulation of ErbB1 and ErbB2 in mammary and epidermoid carcinoma cells, and its inhibitory effect on cell viability was mediated by the 67 kDa laminin receptor (67LR). While 1 was superior in inducing cell death, 2 was more efficient in arresting the tumor cells in the G(2)/M phase. Furthermore, number and brightness analysis revealed that 1 decreased the homoclustering of a lipid raft marker, glycosylphosphatidylinositol-anchored GFP, and it also reduced the co-localization between lipid rafts and 67LR. The main conclusion made is that the primary target of 1 may be the lipid raft component of the plasma membrane followed by secondary changes in the expression of ErbB proteins. Compound 2, on the other hand, must have other unidentified targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据